SpaceX and OpenAI IPO Valuations Could Surpass Berkshire Hathaway on Debut Day Traders Bet SpaceX Scrubs Starship Test Flight Targets Friday Launch for V3 Debut Brookings Study Examines Data Center Employment Impact on Local Economies Consumer Price Index Rises 38 Annually in April Exceeding Expectations Taylor Swifts Chart Streak Stalled Alex Warrens Ordinary Blocks No 1 for 12th Week Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Momentum AMT Q1 2026 Earnings Strong EPS Beat Driven by Portfolio Growth and Margin Expansion SKIN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 421 PNR Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed Stock Slips ECCW Q4 2025 Earnings EPS Beats Estimates by 1379 as Net Investment Income Surges WRB Q1 2026 Earnings Strong Underwriting and Investment Performance Drive 124 EPS Beat DIOD Q1 2026 Earnings EPS Surges Past Estimates Stock Climbs 35 DarioHealth Holds Steady at 77 Consolidation Near Resistance in a Flat Session Gesher Acquisition Corp II GSHR Holds Steady at 1038 as SPAC Consolidates Near Trust Value Organogenesis Holdings ORGO Holds Steady at 266 Consolidation Phase in Play Voya Global Equity Dividend and Premium Opportunity Fund IGD Holds Steady as Dividend Focus Supports Stability Cementos Pacasmayo CPAC Holds Steady Near Resistance as Investors Weigh Sector Fundamentals PANL Q1 2026 Earnings EPS Beats Estimates Amid Broader Market Headwinds BellRing Brands BRBR Q1 2026 Earnings EPS Miss of 565 Triggers Slight Stock Decline OSBC Q1 2026 Earnings Earnings Miss but Stable Share Price USAC Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Biohaven Ltd BHVN Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline Legend Biotech LEGN Q1 2026 Earnings Significant EPS Miss Against Estimates as Stock Rises BlueCollar Workers Emerge as Key Players in AIDriven Economy Says ATT CEO Cantaloupe Inc CTLP Q1 2026 Earnings EPS Misses Estimates by 50 TherapeuticsMD TXMD Edges Higher as Support Holds Near 201 BLK Q1 2026 Earnings Strong EPS Beat Driven by Fee Income and Asset Growth PGY Q1 2026 Earnings Massive EPS Beat of 263 Surprises Market Stock Declines Slightly YB Q2 2025 Earnings EPS of 092 Drives DoubleDigit Stock Rally EPAM Q1 2026 Earnings EPS Beats Estimates Modestly Amid Subdued Market Reaction ALAB Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 104 Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development